CRBU
Caribou Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.57
+0.00%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$0.29
- Revenue estimate
- $2.2M
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.24
- EPS estimate
- -$0.32
- Revenue actual
- $1.5M
- Revenue estimate
- $2.3M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- +18.4%
- Revenue beats (12Q)
- 6
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026